Network origin in Xiaoli Liu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xiaoli Liu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MODERNA, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Sales & Marketing | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Alltrna
Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Biotechnology | Chairman Director/Board Member | |
CURIS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Consultant / Advisor | |
LANTHEUS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
Pennsylvania Biotechnology Center of Bucks County | Director/Board Member | ||
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Medical Specialties | Director/Board Member | |
Gettysburg College | College/University | Undergraduate Degree | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Medical/Nursing Services | Director/Board Member | |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member | |
AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universida de Alcalá de Henares | College/University | Graduate Degree | |
AVANTOR, INC. | Chemicals: Specialty | Director/Board Member | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member | |
New Xellia Group A/S
New Xellia Group A/S Financial ConglomeratesFinance New Xellia Group A/S operates as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Odyssey Partners Ltd.
Odyssey Partners Ltd. Investment ManagersFinance Odyssey Partners Ltd. (OPL) is an independent private equity investment firm located in London. Established in 2000 by Julian Fellerman and Richard Kleiner, OPL is the investment adviser of Avanti Capital Plc. (LSE: AVA), a UK-based private equity firm. | Investment Managers | Corporate Officer/Principal | |
GENOCEA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
London Business School | College/University | Masters Business Admin | |
University of Durham | College/University | Undergraduate Degree | |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
St. Joseph's University | College/University | Masters Business Admin | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
The Nathaniel Adamczyk Foundation | Director/Board Member | ||
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Chairman |
Statistics
International
United States | 39 |
United Kingdom | 8 |
Denmark | 3 |
Switzerland | 2 |
Norway | 2 |
Sectoral
Health Technology | 31 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 5 |
Health Services | 2 |
Operational
Director/Board Member | 108 |
Corporate Officer/Principal | 51 |
Founder | 42 |
Independent Dir/Board Member | 30 |
Chairman | 24 |
Most connected contacts
Insiders | |
---|---|
Noubar Afeyan | 76 |
Julie McHugh | 26 |
Jose-Carlos Gutiérrez-Ramos | 24 |
John Hohneker | 19 |
Nancy Simonian | 17 |
Neil Graham | 14 |
Jonathan Michael Poole | 9 |
Jonathan Zung | 9 |
Juan Andres | 7 |
Luca Scavo | 7 |
Mark D. Plinio | 7 |
Stephen J. Carriere | 4 |
Kareem Reda | 4 |
Julie Carretero | 4 |
Iain Mcinnes | 3 |
- Stock Market
- Insiders
- Xiaoli Liu
- Company connections